SCHEMBL6873197

SCHEMBL6873197

CCCCCCCCCCC(CCCCCCCCCC)(C(=O)OC)C(CCCCCCCCCC)(CCCCCCCCCC)C(=O)OCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
MAPT P10636 1/20 0.57
KMT2A Q03164 1/20 0.57
ATM Q13315 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
HTT P42858 1/20 0.49
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
PKM P14618 2/20 0.46
THRB P10828 1/20 0.46
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
ZDHHC7 Q9NXF8 1/20 0.40
EPHX1 P07099 2/20 0.39
CES2 O00748 1/20 0.38
NAAA Q02083 1/20 0.36
DGKA P23743 1/20 0.36
GGPS1 O95749 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6871664 0.93 MEN1 (0.59) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL6873127 0.91 MEN1 (0.47) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL6871547 0.81 MAPT (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL6863717 0.79 NAAA (0.48) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL888477 0.78 MEN1 (0.45) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL8673442 0.78 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL8216269 0.77 MEN1 (0.59) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL718008 0.77 CYP4F2 (0.61) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL11063113 0.77 MEN1 (0.59) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL7516322 0.77 MEN1 (0.59) MEN1MAPTKMT2AATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed
EP-1165633-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2002-01-02 EP disclosed
WO-2001057099-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 MEN1 4525/4885MAPT 2834/4885KMT2A 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.